JP4545632B2 - Folic acid-containing composition and method for stabilizing folic acid - Google Patents
Folic acid-containing composition and method for stabilizing folic acid Download PDFInfo
- Publication number
- JP4545632B2 JP4545632B2 JP2005127014A JP2005127014A JP4545632B2 JP 4545632 B2 JP4545632 B2 JP 4545632B2 JP 2005127014 A JP2005127014 A JP 2005127014A JP 2005127014 A JP2005127014 A JP 2005127014A JP 4545632 B2 JP4545632 B2 JP 4545632B2
- Authority
- JP
- Japan
- Prior art keywords
- folic acid
- acid
- vitamin
- stabilizing
- folic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims description 334
- 235000019152 folic acid Nutrition 0.000 title claims description 174
- 239000011724 folic acid Substances 0.000 title claims description 174
- 229960000304 folic acid Drugs 0.000 title claims description 170
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims description 169
- 239000000203 mixture Substances 0.000 title claims description 62
- 238000000034 method Methods 0.000 title claims description 34
- 230000000087 stabilizing effect Effects 0.000 title claims description 22
- 235000013361 beverage Nutrition 0.000 claims description 36
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 claims description 21
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 claims description 21
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 21
- 235000005487 catechin Nutrition 0.000 claims description 21
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 14
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 14
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 11
- 229950001002 cianidanol Drugs 0.000 claims description 11
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 10
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 claims description 10
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 9
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 7
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 6
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims description 5
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 5
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 claims description 5
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims description 5
- 235000012734 epicatechin Nutrition 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 claims description 3
- 241001122767 Theaceae Species 0.000 claims 1
- 235000013824 polyphenols Nutrition 0.000 description 35
- -1 folic acid compound Chemical class 0.000 description 23
- 150000008442 polyphenolic compounds Chemical class 0.000 description 21
- 244000269722 Thea sinensis Species 0.000 description 20
- 235000013616 tea Nutrition 0.000 description 19
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 17
- 235000013305 food Nutrition 0.000 description 17
- 238000002156 mixing Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 230000006641 stabilisation Effects 0.000 description 13
- 238000011105 stabilization Methods 0.000 description 13
- 239000000284 extract Substances 0.000 description 11
- 235000013311 vegetables Nutrition 0.000 description 11
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 10
- 150000001765 catechin Chemical class 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 150000002224 folic acids Chemical class 0.000 description 10
- 235000006468 Thea sinensis Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 229910052725 zinc Inorganic materials 0.000 description 9
- 239000011701 zinc Substances 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000019156 vitamin B Nutrition 0.000 description 8
- 239000011720 vitamin B Substances 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 229920000139 polyethylene terephthalate Polymers 0.000 description 7
- 239000005020 polyethylene terephthalate Substances 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 235000020333 oolong tea Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 229930003270 Vitamin B Natural products 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 4
- 240000008620 Fagopyrum esculentum Species 0.000 description 4
- 235000009337 Spinacia oleracea Nutrition 0.000 description 4
- 244000300264 Spinacia oleracea Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- QYNUQALWYRSVHF-OLZOCXBDSA-N (6R)-5,10-methylenetetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1C1)N)N1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-OLZOCXBDSA-N 0.000 description 3
- MSTNYGQPCMXVAQ-NEPJUHHUSA-N 6R-Tetrahydrofolic acid Chemical class C([C@@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-NEPJUHHUSA-N 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000018823 dietary intake Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940014144 folate Drugs 0.000 description 3
- 125000003929 folic acid group Chemical group 0.000 description 3
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000019553 vascular disease Diseases 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AUFGTPPARQZWDO-YPMHNXCESA-N 10-formyltetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)N(C=O)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 AUFGTPPARQZWDO-YPMHNXCESA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- MEANFMOQMXYMCT-OLZOCXBDSA-N 5,10-methenyltetrahydrofolic acid Chemical compound C([C@H]1CNC2=C([N+]1=C1)C(=O)N=C(N2)N)N1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C([O-])=O)C=C1 MEANFMOQMXYMCT-OLZOCXBDSA-N 0.000 description 2
- 229940105150 5-methyltetrahydrofolic acid Drugs 0.000 description 2
- OZRNSSUDZOLUSN-UHFFFAOYSA-N 7,8-Dihydrofolic acid Natural products C1NC=2NC(N)=NC(=O)C=2N=C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-UHFFFAOYSA-N 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 241000219172 Caricaceae Species 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000010749 Vicia faba Nutrition 0.000 description 2
- 240000006677 Vicia faba Species 0.000 description 2
- 235000002098 Vicia faba var. major Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000011987 flavanols Nutrition 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
- 235000011957 flavonols Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000021384 green leafy vegetables Nutrition 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 235000021012 strawberries Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KBPZVLXARDTGGD-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;iron Chemical compound [Fe].OC(=O)C(O)C(O)C(O)=O KBPZVLXARDTGGD-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- BOEUHAUGJSOEDZ-UHFFFAOYSA-N 2-amino-5,6,7,8-tetrahydro-1h-pteridin-4-one Chemical group N1CCNC2=C1C(=O)N=C(N)N2 BOEUHAUGJSOEDZ-UHFFFAOYSA-N 0.000 description 1
- HNXQXTQTPAJEJL-UHFFFAOYSA-N 2-aminopteridin-4-ol Chemical group C1=CN=C2NC(N)=NC(=O)C2=N1 HNXQXTQTPAJEJL-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- YCWUVLPMLLBDCU-UHFFFAOYSA-N 5-Formiminotetrahydrofolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=N)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 YCWUVLPMLLBDCU-UHFFFAOYSA-N 0.000 description 1
- YCWUVLPMLLBDCU-STQMWFEESA-N 5-formimidoyltetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1C=N)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YCWUVLPMLLBDCU-STQMWFEESA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 229940123413 Angiotensin II antagonist Drugs 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- DNAFLRMNKSKEMB-YUZLPWPTSA-N C(=N)N(C1=CC=C(C(N[C@@H](CCC(=O)O)C(=O)O)=O)C=C1)CC1CNC=2N=C(N)NC(=O)C2N1 Chemical compound C(=N)N(C1=CC=C(C(N[C@@H](CCC(=O)O)C(=O)O)=O)C=C1)CC1CNC=2N=C(N)NC(=O)C2N1 DNAFLRMNKSKEMB-YUZLPWPTSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 1
- 244000130270 Fagopyrum tataricum Species 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 201000010829 Spina bifida Diseases 0.000 description 1
- 208000006097 Spinal Dysraphism Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003173 antianemic agent Substances 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 229960003827 isosorbide mononitrate Drugs 0.000 description 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000002816 microbial assay Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 229940082615 organic nitrates used in cardiac disease Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000015040 sparkling wine Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Tea And Coffee (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
本発明は、安定化された葉酸含有組成物、特に飲料として有益な液体組成物、および葉酸の安定化方法に関する。 The present invention relates to stabilized folic acid-containing compositions, particularly liquid compositions useful as beverages, and methods for stabilizing folic acid.
1.葉酸とは;
葉酸は、ほうれん草から始めて抽出されたビタミンB群に属する水溶性ビタミンであり、人参、かぼちゃ等の野菜、アボガド等の果物、豆類、牛乳、黄卵、レバー、などに多く含まれている。
葉酸が、赤血球の産生やタンパク質の代謝あるいは核酸(DNAやRNA)の産生に重要なかかわりを有し、体細胞の分化・増殖に不可欠であり、また糖やアミノ酸消費にも不可欠であるなど、多くの有益な作用を有することは既によく知られている。
更に詳しくは、例えば、葉酸の作用の1つとして、細胞の中でホモシステインがたんぱく質の合成に必要なメチオニンに変換される反応を助ける働きをすることが知られている。
また、葉酸は、上記のとおり、細胞の分化・増殖やDNA合成に不可欠なものであって、特に胎児の細胞増殖が盛んな妊娠初期は、大変重要である。近年では、受胎前後に十分量の葉酸を摂取することで二分脊椎や無脳症などの神経管閉鎖障害のリスクが低減できることが多くの研究から明らかになってきており、厚生労働省では一般成人で240μg/日、妊婦で440μg/日の葉酸を摂ることを推奨している。
1. What is folic acid;
Folic acid is a water-soluble vitamin belonging to the group B vitamins extracted from spinach and is abundant in vegetables such as carrots and pumpkins, fruits such as avocado, beans, milk, yellow eggs and liver.
Folic acid is important for red blood cell production, protein metabolism or nucleic acid (DNA and RNA) production, is essential for somatic cell differentiation and proliferation, and is also essential for sugar and amino acid consumption. It is already well known that it has many beneficial effects.
More specifically, for example, as one of the actions of folic acid, it is known that it functions to help the reaction in which homocysteine is converted into methionine necessary for protein synthesis in the cell.
Further, as described above, folic acid is indispensable for cell differentiation / proliferation and DNA synthesis, and is particularly important in the early stage of pregnancy when fetal cell proliferation is thriving. In recent years, many studies have revealed that taking sufficient folic acid before and after conception can reduce the risk of neural tube closure disorders such as spina bifida and anencephalopathy. 440 μg / day folic acid is recommended for pregnant women / day.
また、葉酸は、ビタミンB12と協働してヘモグロビンの合成を助け赤血球を作る作用を有する。したがって、葉酸とビタミンB12からなる組成物は造血剤として有用である。さらに、同じく赤血球の産生に不可欠なビタミンB6が適切に吸収されるためにはビタミンB12が必要なことから、赤血球の造血のためにはビタミンB12、ビタミンB6及び葉酸の組み合わせが重要な意味を持っている。また、亜鉛が葉酸の吸収を促進する作用を有することから、葉酸組成物に加えて亜鉛を配合することは更に有効である。 In addition, folic acid has a function of cooperating with vitamin B 12 to help synthesize hemoglobin and produce red blood cells. Thus, a composition consisting of folic acid and vitamin B 12 is useful as a hematopoietic agent. Furthermore, also since the required vitamin B 12 in order to vitamin B 6 essential for the production of red blood cells is properly absorbed, vitamin B 12 for hematopoietic erythrocytes, a combination of vitamins of B 6 and folic important Have a meaning. Further, since zinc has an action of promoting absorption of folic acid, it is more effective to add zinc in addition to the folic acid composition.
葉酸に関しては、少なくとも適度に高い血中濃度のホモシステインと少なくとも適度に低い血中濃度の葉酸塩およびビタミンB12を有する閉塞性血管病またはアルツハイマー病の患者に対して、葉酸、葉酸塩またはその誘導体、および必要に応じてビタミンB12、および必要に応じて有機ニトレート(たとえばイソソルビドモノニトレートもしくはジニトレート)、またはACE抑制剤もしくはアンギオテンシンIIアンタゴニスト、あるいはNEP/ACE抑制剤またはこれらの2種以上の混合物を投与することからなる、閉塞性血管病またはアルツハイマー病の処置法も報告されている。したがって、葉酸とビタミンB12からなる医薬組成物は、上記のごとき赤血球増多作用があるのみならず、閉塞性血管病またはアルツハイマー病の治療薬としても有効である。(例えば、特許文献1参照。)
このように、胎児から高齢者に至るまで、葉酸は人体にとって重要な栄養素であり、近年葉酸摂取の必要性が益々高まっている。
With respect to folic acid, for patients with occlusive vascular disease or Alzheimer's disease at least moderately elevated blood homocysteine with at least moderately low blood folate and vitamin B 12 concentrations of concentration, folic acid, folates or Derivatives, and optionally vitamin B 12 , and optionally organic nitrates (eg isosorbide mononitrate or dinitrate), or ACE inhibitors or angiotensin II antagonists, or NEP / ACE inhibitors or mixtures of two or more thereof A method for the treatment of obstructive vascular disease or Alzheimer's disease comprising the administration of Accordingly, the pharmaceutical composition comprising folic acid and vitamin B 12 are not only red blood cells increase multifunctional, such as described above is effective for the treatment of occlusive vascular disease or Alzheimer's disease. (For example, refer to Patent Document 1.)
Thus, folic acid is an important nutrient for the human body from fetuses to elderly people, and in recent years, the need for folic acid intake is increasing.
2.葉酸化合物;
「葉酸」とは、狭義にはプロテイルモノグルタミン酸(合成葉酸)を指すが、広義には、補酵素型、すなわち還元型、一炭素単位置換型およびこれらのポリグルタミン酸の総称である。合成品(食品添加物)の葉酸は食物由来の葉酸に比べ、生体内の利用率が高いといわれている。これら合成品(食品添加物)は、BASF武田ビタミン株式会社及びディー・エス・エムジャパン株式会社等から入手できる。また、食物由来の場合は、緑茶、烏龍茶、紅茶等の茶類、大豆、ソラマメ等の豆類、からし菜、ほうれん草、みずかけ菜、なば菜、グリーンアスパラガス、春菊、サツマイモ、ブロッコリー、チンゲン菜等の野菜、いちご、パパイヤ、オレンジ、ミカン等の果物類から定法に従って抽出したものが使用可能である。これら植物からの葉酸抽出は、茶葉の場合は、温水乃至熱湯で抽出することによって、豆類、野菜類、果物類の場合は、搾汁液から不溶性画分を除き、抽出液を回収することによって達成される。
2. Folic acid compounds;
“Folic acid” refers to proteyl monoglutamic acid (synthetic folic acid) in a narrow sense, but in a broad sense, it is a coenzyme type, that is, a reduced type, a one-carbon unit substitution type, and a general term for these polyglutamic acids. Synthetic products (food additives) folic acid is said to have a higher utilization rate in vivo than food-derived folic acid. These synthetic products (food additives) can be obtained from BASF Takeda Vitamin Co., Ltd. and DSM Japan Co., Ltd. In the case of food origin, teas such as green tea, oolong tea, black tea, beans such as soybeans and broad beans, mustard greens, spinach, mizukake greens, nabara greens, green asparagus, spring chrysanthemum, sweet potatoes, broccoli, tinning What was extracted from fruits, such as vegetables, such as vegetables, strawberries, papayas, oranges, mandarin oranges according to a usual method, can be used. Extraction of folic acid from these plants is achieved by extracting with hot water or hot water in the case of tea leaves, and in the case of beans, vegetables and fruits, removing the insoluble fraction from the juice and collecting the extract. Is done.
3.葉酸化合物の化学構造;
葉酸化合物は、下記プテリン構造を有するものである。
3. Chemical structure of folic acid compounds;
The folic acid compound has the following pterin structure.
より詳しくは、葉酸は下記式で表される。 More specifically, folic acid is represented by the following formula.
上記において、グルタミン酸残基の不斉α−C原子がS−立体配置(αS)で存在するかまたはR−立体配置(αR)で存在し得る。葉酸エステルおよびその他の誘導体についても同様のことが言える。これらは(αS)−葉酸エステルおよび(αR)−葉酸エステルと呼ぶ。天然に産する葉酸 は(αS)−葉酸に相当する。 In the above, the asymmetric α-C atom of the glutamic acid residue may be present in the S-configuration (αS) or in the R-configuration (αR). The same is true for folic acid esters and other derivatives. These are referred to as (αS) -folate and (αR) -folate. Naturally produced folic acid corresponds to (αS) -folic acid.
還元型のテトラヒドロ葉酸は下記式で表される。 Reduced tetrahydrofolic acid is represented by the following formula.
この場合グルタミン酸残基の不斉α−炭素原子がS−立体配置(αS)で存在するかまたはR−立体配置(αR)で存在し、そしてテトラヒドロプテリン残基中の6位の不斉炭素原子がR−立体配置(6R)で存在するかまたはS−立体配置(6S)で存在し得る。テトラヒドロ葉酸のジアステレオマーは(6S,αS)−、(6S,αR)−、(6R,αS)−および(6R,αR)−テトラヒドロ葉酸と呼ぶことができる。テトラヒドロ葉酸エステルおよびその他誘導体についても同様なことが言える。これらは(6S,αS)−、(6S,αR)−、(6R,αS)−および(6R,αR)−テトラヒドロ葉酸エステルと称することができる。天然に産するテトラヒドロ葉酸は(6S,αS)−テトラヒドロ葉酸に相当する。(例えば、特許文献2参照。) In this case the asymmetric α-carbon atom of the glutamic acid residue is present in the S-configuration (αS) or in the R-configuration (αR) and the asymmetric carbon atom at position 6 in the tetrahydropterin residue May exist in the R-configuration (6R) or in the S-configuration (6S). The diastereomers of tetrahydrofolic acid can be referred to as (6S, αS)-, (6S, αR)-, (6R, αS)-and (6R, αR) -tetrahydrofolic acid. The same applies to tetrahydrofolate esters and other derivatives. These can be referred to as (6S, αS)-, (6S, αR)-, (6R, αS)-and (6R, αR) -tetrahydrofolate. Naturally occurring tetrahydrofolic acid corresponds to (6S, αS) -tetrahydrofolic acid. (For example, see Patent Document 2.)
その他、還元型葉酸の1つとして7,8−ジヒドロ葉酸も知られている。
また、5位及び/又は10位が置換された葉酸も知られている。例えば、5−メチルテトラヒドロ葉酸
、5,10−メチレンテトラヒドロ葉酸、5−ホルミルテトラヒドロ葉酸、5−ホルムイミノテトラヒドロ葉酸、10−ホルミルテトラヒドロ葉酸、5,10−メテニルテトラヒドロ葉酸等である。
また、還元型葉酸のあるものは、重合型のポリグルタミル葉酸(2から8グルタミン酸残基を有する。例えば、ジグルタミル葉酸、トリグルタミル葉酸、テトラグルタミル葉酸、ペンタグルタミル葉酸およびヘキサグルタミル葉酸等)としても知られている。
重合型のポリグルタミル葉酸の化学構造式は下記のとおりである。
In addition, 7,8-dihydrofolic acid is also known as one of the reduced folic acids.
Further, folic acid substituted at the 5-position and / or the 10-position is also known. For example, 5-methyltetrahydrofolic acid, 5,10-methylenetetrahydrofolic acid, 5-formyltetrahydrofolic acid, 5-formiminotetrahydrofolic acid, 10-formyltetrahydrofolic acid, 5,10-methenyltetrahydrofolic acid, and the like.
Some of the reduced folic acid can also be used as polymerized polyglutamyl folic acid (having 2 to 8 glutamic acid residues. For example, diglutamyl folic acid, triglutamyl folic acid, tetraglutamyl folic acid, pentaglutamyl folic acid and hexaglutamyl folic acid). Are known.
The chemical structural formula of polymerized polyglutamyl folic acid is as follows.
ここで、nは1乃至7の整数であり、5位及び10位の窒素原子はメチル基、ホルミル基、ホルムイミノ基で置換されてもよく、あるいは5位、10位が互いにメチレン基、メテニル基によって結合されて環を形成してもよい。 Here, n is an integer of 1 to 7, and the nitrogen atoms at the 5th and 10th positions may be substituted with a methyl group, a formyl group or a formimino group, or the 5th and 10th positions are each a methylene group or a methenyl group. May be combined to form a ring.
4.他のビタミンB類(ビタミンB12、ビタミンB6);
上記葉酸は、ビタミンB6, B12, C がなくては十分にその効果を発揮しないとの報告もなされている。
また、これらビタミンB12やビタミンB6についても、様々な有益な作用を有することが知られている。
例えば、ビタミンB12は、水溶性であり、コバルトと結合されることによってその効果を発揮し、赤血球を形成乃至再生して貧血を防ぎ、成長を促進し、脂肪、炭水化物、たんぱく質の使用を適切にコントロールし、刺激に対する過敏な反応を抑制し、また集中力、記憶力を高め、精神を安定させる作用を有する。したがって、ビタミンB12が欠乏すると悪性貧血、神経障害を引き起こす。ビタミンB12も、葉酸と同様、光や酸、アルカリに対して不安定である。
ビタミンB6は、ピリドキシンとも呼ばれる水溶性のビタミンであり、摂取後8時間以内に排泄されることから毎日補給する必要がある。ビタミンB6は、ビタミンB12の存在下に適切に吸収され、抗体や赤血球の産生あるいは胃酸分泌に不可欠であり、たんぱく質と脂肪の適切な吸収を助け、必須アミノ酸のトリプトファンがビタミンB3(ナイアシン)に転換するのを助け、神経や皮膚のさまざまな障害の予防し、抗老化の核酸の正常な合成を促進する作用を有する。したがって、ビタミンB6が欠乏すると、貧血、脂漏性皮膚炎、舌炎の原因ともなる。しかしながら、ビタミンB6も、他のビタミンBと同様、必ずしも安定ではなく長期保存が困難である等の問題を抱えている。
4). Other vitamins B (vitamin B 12 , vitamin B 6 );
It has also been reported that the above folic acid does not sufficiently exert its effects without vitamins B 6 , B 12 and C.
In addition, these vitamin B 12 and vitamin B 6 are also known to have various beneficial effects.
For example, vitamin B 12 is a water-soluble, exerts its effect by being combined with cobalt, erythrocyte formation or regeneration to prevent anemia, promote growth, fat, carbohydrates, the use of protein appropriate It has the action of controlling the sensitivity, suppressing the sensitive reaction to the stimulus, increasing the concentration and memory, and stabilizing the mind. Therefore, pernicious anemia and vitamin B 12 is depleted, causing a neurological disorder. Vitamin B 12 is also unstable to light, acid, and alkali, like folic acid.
Vitamin B 6 is a water-soluble vitamin, also known as pyridoxine, it is necessary to replenish daily from being excreted within 8 hours after ingestion. Vitamin B 6 is properly absorbed in the presence of vitamin B 12 and is essential for the production of antibodies and erythrocytes or gastric acid secretion, assists in the proper absorption of proteins and fats, and the essential amino acid tryptophan is vitamin B 3 (niacin). ), Prevent various nerve and skin disorders, and promote normal synthesis of anti-aging nucleic acids. Accordingly, the vitamin B 6 is depleted, anemia, seborrheic dermatitis, also causes glossitis. However, like other vitamin B, vitamin B 6 also has problems such as being not always stable and difficult to store for a long time.
5.葉酸の安定性;
上記のとおり、近年、葉酸摂取の必要性が益々高まっているが、残念ながら葉酸は、必ずしも安定な化合物ではない。これら葉酸化合物が安定に存在し得るのは弱酸性から中性領域の限られた領域である。したがって、強酸性下では、葉酸は安定に存在することが不可能となる。また、葉酸は光によっても分解するので、PETボトル飲料に適用するにあたっても問題があった。
このように天然物由来の葉酸等のビタミン類は、非常に不安定であって、酸のみならず、経時的に酸素、熱、光などにより分解し、p−アミノ安息香酸、その他複雑な化合物を生じ、経時と共に葉酸量は低下してしまう傾向にあることが知られている。それ故、市販されている缶容器、紙容器、特にペットボトルなどの飲料においては、実際飲用する際には葉酸が必要摂取量をかなり下回る量しか含有していない場合がほとんどである。
5). Stability of folic acid;
As described above, the need for folic acid intake has increased in recent years, but unfortunately folic acid is not always a stable compound. These folic acid compounds can exist stably in a limited region from weakly acidic to neutral regions. Therefore, under strong acidity, folic acid cannot be present stably. Moreover, since folic acid is decomposed by light, there is a problem in applying it to PET bottle beverages.
In this way, vitamins such as folic acid derived from natural products are very unstable, and are decomposed not only by acid but also by oxygen, heat, light, etc. over time, p-aminobenzoic acid, and other complex compounds It is known that the amount of folic acid tends to decrease with time. Therefore, in beverages such as commercially available can containers, paper containers, especially PET bottles, when drinking, folic acid is often contained in an amount considerably lower than the required intake.
6.葉酸の安定化;
これら問題を解決する方法として、例えば、酸に対する葉酸の安定化方法として、エリスリトール及び/又はトレハロースを配合する方法が提案されている。(例えば、特許文献3参照。)。
また、(6R)−、(6S)−又は(6R,S)−5,10−メチレンテトラヒドロ葉酸及びその塩の安定化方法として、それら葉酸水性溶液に、α− 、β−又はγ−シクロデキストリン又はα−、β−
又はγ−シクロデキストリンの誘導体を添加して安定化する方法も提案されている。(例えば、特許文献4参照。)
また、5,6,7,8−テトラヒドロ葉酸およびその誘導体の安定化法方法として、これら化合物の粉末を、不活性ガスの存在下脱酸素剤を共存させて、外気遮断して低温保存することによる安定化方法も提案されている。(例えば、特許文献5参照。)
しかしながら、これら安定化方法は、葉酸の安定化という観点においては目的を達成し得るものの、サイクロデキストリン等の配合剤はあくまで安定化のための第3成分以上の役割を演じるものではなかった。
As a method for solving these problems, for example, a method of blending erythritol and / or trehalose has been proposed as a method for stabilizing folic acid against acid. (For example, refer to Patent Document 3).
Further, as a method for stabilizing (6R)-, (6S)-or (6R, S) -5,10-methylenetetrahydrofolic acid and salts thereof, α-, β- or γ-cyclodextrin is added to these aqueous folic acid solutions. Or α-, β-
Alternatively, a method of stabilizing by adding a derivative of γ-cyclodextrin has been proposed. (For example, see Patent Document 4)
In addition, as a method for stabilizing 5,6,7,8-tetrahydrofolic acid and its derivatives, these compound powders should be stored at low temperature in the presence of an inert gas in the presence of an oxygen scavenger, blocking the outside air. A stabilization method using the above has also been proposed. (For example, refer to Patent Document 5.)
However, although these stabilization methods can achieve the purpose in terms of stabilization of folic acid, compounding agents such as cyclodextrin did not play a role more than the third component for stabilization.
本発明の目的は、単なる葉酸の安定化に止まらず、薬学的に有効な第3成分を用いることによってこれら葉酸を安定化することであり、他の目的は薬学的に有効な第3成分を含む安定化されたビタミンB類含有組成物、特に葉酸含有組成物を提供することである。 The object of the present invention is not only to stabilize folic acid, but also to stabilize these folic acids by using a pharmaceutically effective third component, and the other object is to provide a pharmaceutically effective third component. It is to provide a stabilized vitamin B-containing composition, particularly a folic acid-containing composition.
本発明者らは、上記課題を解決するために鋭意研究を重ねた結果、本発明を完成するに到った。より詳しくは、本発明者らは、既に、多年にわたって食用に供され、人体に対する安全性が確認されている食品素材を調べ、ビタミンB類、特に葉酸の安定化成分として利用価値のあるものを検討した。その結果、ポリフェノール類化合物にビタミンB類、特に葉酸に対する強い安定化作用、特に水溶液中における葉酸等の光に対する安定化作用を有することを見出して本発明に至ったものである。
より具体的には、本発明は以下のとおりである。
As a result of intensive studies to solve the above problems, the present inventors have completed the present invention. More specifically, the present inventors have examined food materials that have been used for food for many years and have been confirmed to be safe for the human body, and those that have utility value as stabilizing components for vitamin Bs, particularly folic acid. investigated. As a result, the present inventors have found that the polyphenol compound has a strong stabilizing action against vitamin Bs, particularly folic acid, particularly a stabilizing action against light such as folic acid in an aqueous solution.
More specifically, the present invention is as follows.
1.葉酸1モルに対して、0.05モル以上の茶由来のエピガロカテキンガレート、エピカテキンガレート、エピガロカテキン及びエピカテキンから選ばれる1種以上のカテキン類を配合することを特徴とする葉酸含有組成物の安定化方法。
2.葉酸含有組成物が飲料組成物である請求項1に記載の葉酸含有組成物の安定化方法。
3.葉酸濃度が24μg/500mL乃至4,800μg/500mLであり、カテキン類含量が100mg/500mL乃至1,000mg/500mLである請求項2に記載の葉酸含有組成物の安定化方法。
4.カテキン類がエピガロケテキンガレートである請求項1乃至請求項4のいずれか1項に記載の葉酸含有組成物の安定化方法。
5.葉酸が、葉酸、ジヒドロ葉酸、テトラヒドロ葉酸及びその誘導体、重合型のポリグルタメート及びその誘導体、そのエステル体及びその塩から選ばれる1種以上の葉酸である請求項1乃至4のいずれか1項に記載の葉酸含有組成物の安定化方法。
1. 1 mol of folic acid, folic acid containing at least 0.05 mol of tea-derived epigallocatechin gallate, epicatechin gallate, epigallocatechin and epicatechin A method of stabilizing the composition.
2. The method for stabilizing a folic acid-containing composition according to claim 1, wherein the folic acid-containing composition is a beverage composition.
3. The method for stabilizing a folic acid-containing composition according to claim 2, wherein the folic acid concentration is 24 μg / 500 mL to 4,800 μg / 500 mL, and the catechin content is 100 mg / 500 mL to 1,000 mg / 500 mL.
4). The method for stabilizing a folic acid-containing composition according to any one of claims 1 to 4, wherein the catechin is epigallocatechin gallate.
5). The folic acid is at least one folic acid selected from folic acid, dihydrofolic acid, tetrahydrofolic acid and derivatives thereof, polymerized polyglutamate and derivatives thereof, ester forms thereof and salts thereof. A method for stabilizing a folic acid-containing composition as described.
本発明は、安定化剤としてポリフェノール類化合物を用いることにより、葉酸を安定化し得たものであり、ポリフェノール類自体の効能・効果、薬効を併せて期待することができる。また、ポリフェノール類は、緑茶等に含まれるものであり安全性も確認されていることから、長期に摂取した場合においても何ら問題がない。 In the present invention, folic acid can be stabilized by using a polyphenol compound as a stabilizer, and the efficacy / effect and drug efficacy of the polyphenol itself can be expected. In addition, since polyphenols are contained in green tea and the like and have been confirmed to be safe, there is no problem even when ingested for a long time.
以下に、本発明の実施の態様について説明する。
本明細書において使用する用語の意味は以下のとおりである。
Hereinafter, embodiments of the present invention will be described.
The meanings of terms used in the present specification are as follows.
「安定化された葉酸含有組成物」とは、葉酸が安定した状態で存在し得る葉酸含有組成物を意味し、形態的には、飲料や食品に添加するための葉酸及びポリフェノール類を含有してなる配合用原体としての固体組成物(粉末、錠剤等)、これら固体粉末組成物を飲料用原液に加えてなる飲料等の液体組成物、あるいはこれら固体粉末組成物をガムや飴等の食品に加えてなるガムや飴等の固形組成物として存在し得る。用途面から見た場合、該組成物は、医薬組成物;医薬部外品組成物;薬理効果を備えたいわゆる健康食品(サプリメント);飲料や食品に添加するための配合用組成物(食品添加物);該配合用組成物を添加して飲料とした飲料組成物;又は該配合用組成物を添加して食品とした食品組成物(栄養機能食品、特定保健用食品、機能性食品。)等に区分することができる。 “Stabilized folic acid-containing composition” means a folic acid-containing composition in which folic acid can exist in a stable state, and morphologically contains folic acid and polyphenols for addition to beverages and foods. A solid composition (powder, tablet, etc.) as a raw material for blending, a liquid composition such as a beverage obtained by adding these solid powder compositions to a beverage stock solution, or a solid powder composition such as gum or candy It may be present as a solid composition such as gum or candy in addition to food. From the viewpoint of use, the composition is a pharmaceutical composition; a quasi-drug composition; a so-called health food (supplement) having a pharmacological effect; a composition for blending to be added to a beverage or food (food addition) A beverage composition obtained by adding the blending composition; or a food composition obtained by adding the blending composition to a food (nutrient functional food, food for specified health use, functional food). And so on.
医薬組成物、医薬部外品組成物、薬理効果を備えたいわゆる健康食品(サプリメント)とする場合は、結合剤等の配合剤を適宜加えることによって、定法に従って、タブレット、カプセル、顆粒等の形態とすることにより、より一層摂取し易くすることができる。
配合用組成物として使用する場合は、粉末状の原体のままでもよいし、これを定法に従ってタブレット、カプセル、顆粒等の形態に加工して用いてもよい。
When a pharmaceutical composition, a quasi-drug composition, or a so-called health food (supplement) having a pharmacological effect is added, a formulation such as a tablet, capsule, granule or the like is added according to a conventional method by appropriately adding a compounding agent such as a binder. By making it, it can make it easier to ingest.
When used as a composition for blending, it may be a powdery raw material, or may be processed into a tablet, capsule, granule or the like according to a conventional method.
飲料組成物は、好ましくは容器詰飲料組成物であり、例えば、緑茶、ウーロン茶、紅茶等の茶飲料;リンゴジュース、グレープフルーツジュース、オレンジジュース等のジュース類;果汁配合飲料;野菜汁配合飲料;コーヒー飲料;ココア飲料;牛乳等の乳飲料;コーラ、サイダー等の炭酸飲料;スポーツ飲料;豆乳;ミネラルウォーター;ニアウォーター飲料;ダイエットサポート飲料;栄養補給飲料等である。また、ビール、発泡酒、ワイン、日本酒等のアルコール飲料であってもよい。これら飲料用組成物は、緑茶、ウーロン茶、紅茶等の茶飲料乃至その原材料(例えば、茶抽出液)に、上記配合用組成物を適量配合することによって製造することができる。茶飲料の場合は、茶飲料それ自体にカテキン等のポリフェノール類が含有されているので、結果的に葉酸を安定化されうる範囲で適量配合することによっても製造することができる。 The beverage composition is preferably a containerized beverage composition, for example, tea beverages such as green tea, oolong tea, and tea; juices such as apple juice, grapefruit juice, and orange juice; fruit juice blended beverages; vegetable juice blended beverages; coffee Beverages; Cocoa drinks; Milk drinks such as milk; Carbonated drinks such as cola and cider; Sports drinks; Soy milk; Mineral water; Near water drinks; Diet support drinks; Moreover, alcoholic beverages, such as beer, a sparkling wine, wine, and sake, may be sufficient. These beverage compositions can be produced by blending an appropriate amount of the above composition for blending into a tea beverage such as green tea, oolong tea, black tea or the like (for example, tea extract). In the case of a tea beverage, since the tea beverage itself contains polyphenols such as catechin, it can be produced by blending an appropriate amount of folic acid within the range that can be stabilized as a result.
食品組成物は、上記配合用組成物を原材料に適量配合して定法に従って加工することによって得られる菓子、パン、ヨーグルト、ゼリー、冷菓、キャンデイ、ガム等である。 The food composition is a confectionery, bread, yogurt, jelly, frozen confectionery, candy, gum or the like obtained by blending an appropriate amount of the above composition for blending into raw materials and processing it according to a conventional method.
上記「安定化された葉酸含有組成物」は、好ましくは、ジュース類;果汁配合飲料;野菜汁配合飲料;乳飲料;茶飲料等の飲料組成物である。 The “stabilized folic acid-containing composition” is preferably a beverage composition such as juices; fruit juice-containing beverages; vegetable juice-containing beverages; milk beverages; tea beverages.
また、上記「飲料組成物」は、葉酸、ポリフェノール類化合物に併せて、食品添加物として使用可能な各種の甘味料、酸味料、無機酸塩、無機酸塩類、有機酸、栄養強化剤、酸化防止剤、香料、色素類、乳化剤、保存料、調味料、脂質類、タンパク質類、ペプチド類、多糖類、食物繊維類、果汁エキス類、野菜エキス類、花蜜エキス類、pH調整剤等を単独或いは併用して配合してもよい。
甘味料としては、例えば、砂糖、ブドウ糖、果糖、異性化液糖、グリチルリチン、ステビア、アスパルテーム、フラクトオリゴ糖、環状オリゴ糖、人工甘味料等が挙げられる。
酸味料としては、天然成分から抽出した果汁類の他、クエン酸、酒石酸、リンゴ酸、乳酸、フマル酸、リン酸が挙げられる。
無機酸類、無機酸塩類としては、リン酸、リン酸二ナトリウム、メタリン酸ナトリウム、ポリリン酸ナトリウム等が挙げられる。有機酸類、有機酸塩類としてはクエン酸、コハク酸、イタコン酸、リンゴ酸、クエン酸ナトリウム等が挙げられる。
また、栄養強化剤として、β−カロテン、ビタミンA、葉酸以外の他のビタミンB類(例えば、ビタミンB1、ビタミンB2、ナイアシン、パントテン酸等)、ビオチン、ビタミンC、ビタミンD、ビタミンE、コエンザイムQ10、α-リポ酸、カルニチン、カルシウム、鉄、マグネシウム、亜鉛、銅等が挙げられる。
容器詰飲料に使用される容器は、一般の飲料と同様に、ポリエチレンテレフタレートを主成分とする成形容器(いわゆるPETボトル)、金属管、金属箔やプラスチックフィルムと複合された紙容器、瓶等の通常の形態で提供することができる。好ましくはPETボトルである。また、ここでいう容器詰飲料とは希釈せずに飲用できるものをいう。
In addition, the above-mentioned “beverage composition” includes various sweeteners, acidulants, inorganic acid salts, inorganic acid salts, organic acids, nutrient fortifiers, oxidizing agents that can be used as food additives in addition to folic acid and polyphenol compounds. Inhibitors, fragrances, pigments, emulsifiers, preservatives, seasonings, lipids, proteins, peptides, polysaccharides, dietary fibers, fruit juice extracts, vegetable extracts, nectar extracts, pH adjusters, etc. alone Or you may mix | blend together.
Examples of the sweetener include sugar, glucose, fructose, isomerized liquid sugar, glycyrrhizin, stevia, aspartame, fructooligosaccharide, cyclic oligosaccharide, artificial sweetener and the like.
Examples of the sour agent include citric acid, tartaric acid, malic acid, lactic acid, fumaric acid, and phosphoric acid in addition to fruit juices extracted from natural ingredients.
Examples of inorganic acids and inorganic acid salts include phosphoric acid, disodium phosphate, sodium metaphosphate, and sodium polyphosphate. Examples of organic acids and organic acid salts include citric acid, succinic acid, itaconic acid, malic acid, sodium citrate and the like.
In addition, β-carotene, vitamin A, vitamin B other than folic acid (for example, vitamin B 1 , vitamin B 2 , niacin, pantothenic acid, etc.), biotin, vitamin C, vitamin D, vitamin E , Coenzyme Q10, α-lipoic acid, carnitine, calcium, iron, magnesium, zinc, copper and the like.
Containers used for container-packed beverages, like ordinary beverages, are molded containers mainly composed of polyethylene terephthalate (so-called PET bottles), metal tubes, paper containers combined with metal foil and plastic films, bottles, etc. It can be provided in the usual form. A PET bottle is preferable. Moreover, the container-packed drink here means what can be drunk without dilution.
「葉酸」とは、上記した葉酸;テトラヒドロ葉酸、ジヒドロ葉酸;5位及び/又は10位が置換された置換テトラヒドロ葉酸;及び、重合型のポリグルタメート(2から8のグルタミン酸残基を有する)を意味する。具体例としては、葉酸、7,8−ジヒドロ葉酸、5,6,7,8−テトラヒドロ葉酸、5−メチルテトラヒドロ葉酸、5,10−メチレンテトラヒドロ葉酸、5,10−メテニルテトラヒドロ葉酸、5,10−ホルムイミノテトラヒドロ葉酸、5−ホルミルテトラヒドロ葉酸(ロイコボリン)、5−ホルミルイミノテトラヒドロ葉酸、10−ホルミルテトラヒドロ葉酸、重合型のポリグルタミル葉酸(2から8のグルタミン酸残基を有する)、それらのエステル体、及びそれらの塩、それらの混合物を挙げることができる。
重合型のポリグルタミル葉酸としては、例えば、5−ホルムイミノ−(6S)−テトラヒドロ葉酸等のテトラヒドロ葉酸のジグルタミル、トリグルタミル、テトラグルタミル、ペンタグルタミルおよびヘキサグルタミル誘導体等を挙げることができる。
また、特に限定のない限り、用語「葉酸」は 、両方のエナンチオマー(αS)および(αR)を包含し、そしてテトラヒドロ葉酸については、そのジアステレオマー((6S,αS)、(6S,αR)、(6R,αS)および(6R,αR))を包含する。
テトラヒドロ葉酸誘導体、重合型のポリグルタミル葉酸誘導体における誘導体とは、5位及び/又は10位における置換体を意味する。
本発明において、好ましい葉酸は、生体内の利用効率及び含有量のコントロールの観点からすると上記合成品(食品添加物)に分類される葉酸であり、具体的には、BASF武田ビタミン株式会社製、ディー・エス・エムジャパン株式会社等から入手できる。化学構造面からすると、特に好ましいのはプテロイルモノグルタミン酸である。また、天然物由来の場合は、緑茶、烏龍茶、紅茶等の茶類、大豆、ソラマメ等の豆類、からし菜、ほうれん草、みずかけ菜、なば菜、グリーンアスパラガス、春菊、サツマイモ、ブロッコリー、チンゲン菜等の野菜、いちご、パパイヤ、オレンジ、ミカン等の果物類から得られるもの(抽出されるもの)が使用可能である。これら食物から葉酸を抽出する方法は、茶葉の場合は温水乃至熱湯で抽出する方法、豆類、野菜類、果物類の場合は搾汁液から不溶性画分を除き、抽出液を回収する方法等、公知の一般的な方法を採用することができる。場合によっては、抽出することなくジュース等としてそのまま使用することも可能である。
“Folic acid” refers to folic acid described above; tetrahydrofolic acid, dihydrofolic acid; substituted tetrahydrofolic acid substituted at the 5-position and / or 10-position; and polymerized polyglutamate (having 2 to 8 glutamic acid residues). means. Specific examples include folic acid, 7,8-dihydrofolic acid, 5,6,7,8-tetrahydrofolic acid, 5-methyltetrahydrofolic acid, 5,10-methylenetetrahydrofolic acid, 5,10-methenyltetrahydrofolic acid, 5, 10-formiminotetrahydrofolic acid, 5-formyltetrahydrofolic acid (leucovorin), 5-formyliminotetrahydrofolic acid, 10-formyltetrahydrofolic acid, polymerized polyglutamylfolic acid (having 2 to 8 glutamic acid residues), esters thereof The body and their salts and mixtures thereof.
Examples of the polymerized polyglutamyl folic acid include dihydrotayl, triglutamyl, tetraglutamyl, pentaglutamyl and hexaglutamyl derivatives of tetrahydrofolic acid such as 5-formimino- (6S) -tetrahydrofolic acid.
Also, unless otherwise limited, the term “folic acid” encompasses both enantiomers (αS) and (αR), and for tetrahydrofolic acid, its diastereomers ((6S, αS), (6S, αR) , (6R, αS) and (6R, αR)).
The tetrahydrofolic acid derivative and the derivative in the polymerized polyglutamyl folic acid derivative mean a substituted product at the 5-position and / or the 10-position.
In the present invention, preferred folic acid is folic acid classified into the above-mentioned synthetic product (food additive) from the viewpoint of in vivo utilization efficiency and content control, specifically, BASF Takeda Vitamin Co., Ltd. Available from DSM Japan Inc. From the viewpoint of chemical structure, pteroyl monoglutamic acid is particularly preferred. In addition, if derived from natural products, teas such as green tea, oolong tea, black tea, beans such as soybeans, broad beans, mustard vegetables, spinach, mizukake vegetables, nabara vegetables, green asparagus, spring chrysanthemum, sweet potatoes, broccoli, What can be obtained (extracted) from fruits such as vegetables such as chingen vegetables, strawberries, papayas, oranges and mandarin oranges can be used. Methods for extracting folic acid from these foods are known, such as a method of extracting with hot water or hot water in the case of tea leaves, a method of recovering the extract by removing the insoluble fraction from the juice in the case of beans, vegetables and fruits. The general method can be adopted. In some cases, it is possible to use the juice as it is without extraction.
「ポリフェノール類」とは、水酸基を複数有するフェノール構造を有する一連の化合物を意味し、例えば、フラボン、フラボノール、フラバノン、フラバノール、アントシアニジン、イソフラボンを挙げることができる。具体的には、上記フラボンとしては、ルチン、ルテオリン等を、フラボノールとしてはケルセチン、ケンフェロール等を、フラバノンとしてはヘスペリジン、ナリンジン等を、フラバノールとしてはカテキン類等を、アントシアニジンとしてはシアニジン等を、イソフラボンとしてはゲニステイン、ゲニスチン、ダイゼイン等を挙げることができ、カテキン類としては、エピカテキン、エピガロカテキン、エピカテキンガレート、エピガロカテキンガレート、カテキン、ガロカテキン、カテキンガレート、ガロカテキンガレートを挙げることができる。
その他、クロロゲン酸類、プロトアントシアニジン類、テアフラビン類、テアルビジン類等を挙げることができる。
好ましいポリフェノール類化合物は、カテキン類であり、特に好ましくは茶由来のエピガロカテキンガレート、エピカテキンガレート、エピガロカテキンまたはエピカテキンであり、さらに好ましくはエピカテキンガレートである。
上記ポリフェノール類の由来は特に限定されるものではないが、中でも、茶、コーヒー、ココア、ワイン、ブドウ、リンゴ、ベリー類、チェリー、レモン、オレンジ、シークワーシャー、グレープフルーツ、メロン、タマネギ、ブロッコリー、ホウレンソウ、ニンジン、セロリ、ナス、ニンニク、キャベツ、メキャベツ、キュウリ、ソバ、玄米、大豆、小豆、大麦、バジル、タラゴン、ハッカ、オレガノ、タイム、セージ、ローズマリーおよびそれらの混合物に由来するもの、特に茶に由来するものは、飲料としての応用も容易であり、好適である。特に、茶に含まれるカテキン類は、水溶性に優れ、日常的に飲用される嗜好飲料としての実績からより好ましい。
これら植物原料からポリフェノール類を抽出する方法は、水乃至熱湯で抽出し、残渣をろ過する方法、あるいは搾汁液から不溶性物を取り除く方法等、公知乃至周知の一般的な方法を採用することができる。
“Polyphenols” mean a series of compounds having a phenol structure having a plurality of hydroxyl groups, and examples include flavones, flavonols, flavanones, flavanols, anthocyanidins, and isoflavones. Specifically, as the flavone, rutin, luteolin, etc., as flavonol, quercetin, kaempferol, etc., as flavanone, hesperidin, naringin, etc., as flavanol, catechins, etc., as anthocyanidin, cyanidin, etc., Examples of isoflavones include genistein, genistin, daidzein, and examples of catechins include epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, catechin, gallocatechin, catechin gallate, and gallocatechin gallate. it can.
In addition, chlorogenic acids, protoanthocyanidins, theaflavins, thealvidins and the like can be mentioned.
The preferred polyphenol compounds are catechins, particularly preferably tea-derived epigallocatechin gallate, epicatechin gallate, epigallocatechin or epicatechin, and more preferably epicatechin gallate.
The origin of the above polyphenols is not particularly limited, but among them, tea, coffee, cocoa, wine, grapes, apples, berries, cherry, lemon, orange, sikhshire, grapefruit, melon, onion, broccoli, From spinach, carrots, celery, eggplant, garlic, cabbage, me cabbage, cucumber, buckwheat, brown rice, soybeans, red beans, barley, basil, tarragon, mint, oregano, thyme, sage, rosemary and mixtures thereof, especially Those derived from tea are suitable because they can be easily applied as beverages. In particular, catechins contained in tea are more preferable because of their excellent water solubility and their track record as favorite beverages that are drunk on a daily basis.
As a method for extracting polyphenols from these plant raw materials, a known or well-known general method such as a method of extracting with water or hot water and filtering the residue or a method of removing insoluble substances from the juice can be adopted. .
「ビタミンB12」、「ビタミンB6」とは、特に限定されるものではなく、工業的に生産された市販品であっても、あるいは食物中に含まれる「ビタミンB12」、「ビタミンB6」それ自体であってもよい。 “Vitamin B 12 ” and “Vitamin B 6 ” are not particularly limited, and may be commercially available products produced industrially or “vitamin B 12 ” or “vitamin B” contained in food. 6 "may be a per se.
「亜鉛」とは、食品として、又は医薬品として使用できる亜鉛類、特に体内吸収性を有する亜鉛類であればよく、特に制限されるものでない。 The “zinc” is not particularly limited as long as it is zinc that can be used as a food or as a pharmaceutical, particularly zinc having absorbability in the body.
次に、葉酸及びポリフェノール類の配合量について述べる。
厚生労働省の発表した食事摂取基準(2005年版)によれば葉酸の1日の摂取推奨量は、体重、年令、健康、性別その他の因子に応じて異なるが、成人で240μg/日、妊婦で440μg/日である。
日常的な飲食物から摂取される葉酸の量を考慮すると本発明組成物中に包含される葉酸の最低含量は上記推奨量の約1/10、即ち24μg/日であり、また、過剰に摂取された葉酸は体外に排出されて無害であること、生体内での利用率が50%と見積られる(葉酸は、小腸で消化酵素によって分解されて体内に吸収されるが、吸収・代謝過程で様々な段階を経ることにより生体内での利用率は50%と見積られる。)こと等を考えるとその最高含量は成人推奨量の約20倍、即ち4,800μgとすることができる。
この観点から、本発明の葉酸含有組成物からの適正な葉酸摂取量は、24μg/日乃至4,800μg/日であり、好ましく100μg/日乃至4,800μg/日、特に好ましくは200μg/日乃至4,800μg/日を目安とすることができる。
具体的には、飲料組成物である場合には、1日1本乃至2本を飲用するとして、24μg/500mL乃至4,800μg/500mL、好ましくは100μg/500mL乃至4,800μg/500mL、特に好ましくは200μg/500mL乃至4,800μg/500mLである。PETボトル飲料の場合は、日光に曝される可能性が高いので、さらに高濃度の300μg/500mL乃至4,800μg/500mLが好ましい。
医薬組成物、サプリメント、食品組成物の場合も、上記1日あたりの推奨量に基づいて適宜その含有量を決定すればよい。
なお、本発明のうち葉酸含有組成物の発明にあっては、葉酸に対するポリフェノール類の含量は安定化の観点からして重要であるが、葉酸それ自体の含有量は単に上記推奨量に基づいて適宜決定することができる。
Next, the blending amounts of folic acid and polyphenols will be described.
According to the dietary intake standard (2005 edition) published by the Ministry of Health, Labor and Welfare, the recommended daily intake of folic acid depends on body weight, age, health, sex, and other factors, but 240 μg / day for adults and pregnant women 440 μg / day.
Considering the amount of folic acid taken from daily foods and drinks, the minimum content of folic acid contained in the composition of the present invention is about 1/10 of the recommended amount, that is, 24 μg / day. It is estimated that folic acid is excreted from the body and is harmless, and its utilization rate in vivo is estimated to be 50% (folic acid is decomposed by digestive enzymes in the small intestine and absorbed into the body. In view of the fact that the utilization rate in vivo is estimated to be 50% through various stages, the maximum content can be about 20 times the recommended adult dose, that is, 4,800 μg.
From this viewpoint, the appropriate folic acid intake from the folic acid-containing composition of the present invention is 24 μg / day to 4,800 μg / day, preferably 100 μg / day to 4,800 μg / day, particularly preferably 200 μg / day to A guideline of 4,800 μg / day can be used.
Specifically, in the case of a beverage composition, one or two drinks per day are taken as 24 μg / 500 mL to 4,800 μg / 500 mL, preferably 100 μg / 500 mL to 4,800 μg / 500 mL, particularly preferably Is 200 μg / 500 mL to 4,800 μg / 500 mL. In the case of a PET bottle beverage, since there is a high possibility of exposure to sunlight, an even higher concentration of 300 μg / 500 mL to 4,800 μg / 500 mL is preferable.
In the case of pharmaceutical compositions, supplements, and food compositions, the content may be appropriately determined based on the recommended amount per day.
In the invention of the folic acid-containing composition of the present invention, the content of polyphenols relative to folic acid is important from the viewpoint of stabilization, but the content of folic acid itself is simply based on the above recommended amount. It can be determined as appropriate.
「葉酸を安定化させるのに十分な量のポリフェノール類」等における「安定化」とは、20℃、5,000ルクスの蛍光灯(人工気象器)下に置いた場合に、少なくとも葉酸に対する安定化効果が見出せることを意味し、好ましくは、当該条件下に1週間置いた場合に、葉酸の存存率が少なくとも50%以上、特に好ましくは70%以上であることを意味する。 “Stabilization” in “polyphenols in an amount sufficient to stabilize folic acid” means at least stability to folic acid when placed under a fluorescent lamp (artificial meteor) at 5,000 lux at 20 ° C. It means that the folic acid can be found, preferably when the folic acid is present for at least 1 week under the above conditions, and the presence of folic acid is at least 50%, particularly preferably 70% or more.
本発明の組成物に配合すべきポリフェノール類配合の下限値は葉酸の安定化に必要な最低量を意味し、その最低配合量(共存量)は、後述の実施例から明らかなとおり、葉酸に対しモル比で0.05倍(ECGの場合、重量比で0.05倍)、好ましくは葉酸に対しモル比で0.1倍(ECGの場合、重量比で0.1倍)である。一方、カテキン類等のポリフェノール類は無毒であり体脂肪低減等の効果があるものの、不必要に過剰に添加した場合には、カテキン類特有の苦渋味等の問題が発生することから、ポリフェノール類の含量は、100mg/日乃至1,000mg/日(飲料においては、100mg/500mL乃至1,000mg/500mL)とするのが好ましい。
例えば、葉酸が100μg/日乃至4,800μg/日(100μg/500mL乃至4,800μg/500mL)の場合、その安定化に必要なポリフェノール量の最低量は、ECGで0.05倍の5μg/日乃至240μg/日(飲料の場合は、5μg/500mL乃至240μg/500mL)であり、好ましくは、その0.1倍量の10μg/日乃至480μg/日(10μg/500mL乃至480μg/500mL)である。
しなしながら、必要なポリフェノールを十分に摂取するという観点からすると、ポリフェノール含量は、100mg/日乃至1,000mg/日(飲料の場合は、100mg/500mL乃至1000mg/500mL)とするのが好ましい。このような含量であれば、上記から明らかなとおり、ポリフェノールの摂取も十分であり、かつ、結果的に葉酸も自ずと安定化される。
The lower limit of the blend of polyphenols to be blended in the composition of the present invention means the minimum amount necessary for stabilizing folic acid, and the minimum blending amount (coexistence amount) is the same as that of folic acid as will be apparent from the examples described later. The molar ratio is 0.05 times (in the case of ECG, 0.05 times in weight ratio), preferably 0.1 times in molar ratio to folic acid (in the case of ECG, 0.1 times weight ratio). On the other hand, polyphenols such as catechins are non-toxic and effective in reducing body fat, but if added excessively unnecessarily, problems such as bitterness and astringency peculiar to catechins occur. The content of is preferably 100 mg / day to 1,000 mg / day (in beverages, 100 mg / 500 mL to 1,000 mg / 500 mL).
For example, when folic acid is 100 μg / day to 4,800 μg / day (100 μg / 500 mL to 4,800 μg / 500 mL), the minimum amount of polyphenols required for stabilization is 0.05 times ECG, 5 μg / day. To 240 μg / day (in the case of beverages, 5 μg / 500 mL to 240 μg / 500 mL), preferably 0.1 μg / day to 480 μg / day (10 μg / 500 mL to 480 μg / 500 mL).
However, from the viewpoint of sufficiently ingesting the necessary polyphenols, the polyphenol content is preferably 100 mg / day to 1,000 mg / day (100 mg / 500 mL to 1000 mg / 500 mL for beverages). With such a content, as is apparent from the above, the intake of polyphenol is sufficient, and as a result, folic acid is naturally stabilized.
同じく厚生労働省の食事摂取基準(2005年版)によれば、「ビタミンB12」の1日あたりの推奨量は2.4μg/日であり、他方、葉酸の推奨量が240μg(妊婦で440μg)であることから、「ビタミンB12」を配合する場合は、葉酸に対してその0.005乃至0.05重量倍量を配合することが好ましい。好ましくは、1.2μg/日乃至12μg/日を目安とすることができる。具体的には、飲料組成物である場合には、1日1本乃至2本を飲用するとして、1.2μg/500mL乃至12μg/500mL、である。 Similarly, according to the Ministry of Health, Labor and Welfare's dietary intake standard (2005 version), the recommended daily amount of “Vitamin B 12 ” is 2.4 μg / day, while the recommended amount of folic acid is 240 μg (440 μg for pregnant women). For this reason, when blending “vitamin B 12 ”, it is preferable to blend 0.005 to 0.05 times by weight the amount of folic acid. Preferably, the standard can be 1.2 μg / day to 12 μg / day. Specifically, in the case of a beverage composition, it is 1.2 μg / 500 mL to 12 μg / 500 mL, assuming that one or two drinks per day.
同じく厚生労働省の食事摂取基準(2005年版)によれば、「ビタミンB6」の1日あたりの推奨量は成人男子で1.4mgであり、他方、葉酸の推奨摂取量が240μg(妊婦で440μg)であることから、「ビタミンB6」を配合する場合は、葉酸に対してその3乃至10重量倍量を配合することが好ましい。 Similarly, according to the Ministry of Health, Labor and Welfare's dietary intake standard (2005 edition), the recommended daily dose of “vitamin B 6 ” is 1.4 mg for adult males, while the recommended intake of folic acid is 240 μg (440 μg for pregnant women). Therefore, when blending “vitamin B 6 ”, it is preferable to blend 3 to 10 times the amount of folic acid.
「亜鉛」の1日あたりの推奨量は成人男子で9mg、女性7mgであり、他方、葉酸の推奨量が240μg(妊婦で440μg)であり、更には本発明組成物においては亜鉛は必須ではなく補助的な役割を担うことから、「亜鉛」を配合する場合は、葉酸に対してその10乃至50重量倍量を配合することが好ましい。 The recommended daily amount of “zinc” is 9 mg for adult males and 7 mg for females. On the other hand, the recommended amount of folic acid is 240 μg (440 μg for pregnant women), and zinc is not essential in the composition of the present invention. Since it plays an auxiliary role, when blending “zinc”, it is preferable to blend 10 to 50 times by weight thereof with respect to folic acid.
本発明の葉酸含有組成物、特に飲料組成物は、遮光条件下での保管を組み合わせることにより、さらに葉酸安定化効果を高めることができる。遮光条件下での保管とは、遮光された箱等に透明または不透明の容器に入れた当該飲料の保管、および遮光性の容器に当該飲料を入れた保管など、飲料そのものに直接光を当てないような保管をいう。ここで、遮光条件とは、可視光の約50%以上、好ましくは約70%以上、より好ましくは約90%以上がカットされる状態をいう。また、特に波長の短い光はエネルギーが高いため、波長約340nm以下の光が約80%以上、より好ましくは約90%以上カットされる状態が望ましい。例えば、金属製の缶容器中に充填された場合は、上記遮光条件をほぼ満足する。 The folic acid-containing composition of the present invention, particularly the beverage composition, can further enhance the folic acid stabilization effect by combining storage under light-shielding conditions. Storage under light-shielding conditions means that the beverage itself is not directly exposed to light, such as storage of the beverage in a transparent or opaque container in a light-shielded box or storage of the beverage in a light-shielding container. Such storage. Here, the light-shielding condition refers to a state in which about 50% or more, preferably about 70% or more, more preferably about 90% or more of visible light is cut. In particular, since light with a short wavelength has high energy, it is desirable that light having a wavelength of about 340 nm or less is cut by about 80% or more, more preferably about 90% or more. For example, when filled in a metal can container, the above light shielding conditions are substantially satisfied.
本発明に用いられる葉酸は高速液体クロマトグラフィー法、微生物定量法、ELISA法により定量できる。また、本発明に用いられるポリフェノール類は、高速液体クロマトグラフィー法、酒石酸鉄比色法、フォーリンデニス法、フォーリンチオカルト法等により定量できる。 Folic acid used in the present invention can be quantified by high performance liquid chromatography, microbial assay, or ELISA. Further, the polyphenols used in the present invention can be quantified by a high performance liquid chromatography method, an iron tartrate colorimetric method, a foreign dennis method, a foreign thiocult method, or the like.
以下、本発明を実施例に基づいて更に詳細に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES Hereinafter, although this invention is demonstrated further in detail based on an Example, this invention is not limited to these Examples.
1.葉酸の経時安定性試験;
20mLの50mMリン酸緩衝液(pH6)に葉酸(関東化学株式会社製。分子量441)100μM(終濃度)となるように溶解した。この葉酸溶液に、ポリフェノール類化合物として、それぞれエピガロカテキン(EGC;分子量306)(フナコシ株式会社製)(サンプル1)、エピガロカテキンガレート(EGCG;分子量458)(フナコシ株式会社製)(サンプル2)、エピカテキン(EC;分子量290)(フナコシ株式会社製)(サンプル3)およびエピカテキンガレート(ECG;分子量442)(フナコシ株式会社製)(サンプル4)を10μM(終濃度)添加して、サンプル1〜4とした。これらのサンプルを、25℃、5,000ルクスの人工気象器(日本医化機械製作所製)下に置くことにより、葉酸の経時安定性を試験した。
なお、ここでそれぞれの成分の重量換算値は、葉酸;44.1mg、EGC;3.06mg、EGCG;4.58mg、EC2.9mg、ECG;4.42mgである。
同時に比較例として、葉酸溶液を暗黒下に置いたもの(光照射なし)(サンプル5)、25℃、5,000ルクスの人工気象器下に置いたポリフェノール類化合物なしの葉酸溶液(サンプル6)、ビタミンC(L−アスコルビン酸;和光純薬工業株式会社製)を100μM(終濃度)のみ添加した葉酸溶液(サンプル7)も同様に試験した。
サンプルを一定時間置いた後、経時的に葉酸の測定を行った。また、対照として、同濃度のビタミンCを用いて比較した。
1. Folic acid stability test over time;
In 20 mL of 50 mM phosphate buffer (pH 6), folic acid (manufactured by Kanto Chemical Co., Inc., molecular weight 441) was dissolved to a concentration of 100 μM (final concentration). In this folic acid solution, epigallocatechin (EGC; molecular weight 306) (manufactured by Funakoshi Co., Ltd.) (sample 1), epigallocatechin gallate (EGCG; molecular weight 458) (manufactured by Funakoshi Co., Ltd.) (sample 2) were used as polyphenol compounds. ), Epicatechin (EC; molecular weight 290) (manufactured by Funakoshi Co., Ltd.) (sample 3) and epicatechin gallate (ECG; molecular weight 442) (manufactured by Funakoshi Co., Ltd.) (sample 4) were added at 10 μM (final concentration), Samples 1 to 4 were used. The folic acid was tested for stability over time by placing these samples under an artificial weather apparatus (manufactured by Nippon Medical Chemical Co., Ltd.) at 25 ° C. and 5,000 lux.
In addition, the weight conversion value of each component here is folic acid; 44.1 mg, EGC; 3.06 mg, EGCG; 4.58 mg, EC 2.9 mg, ECG; 4.42 mg.
At the same time, as a comparative example, a folic acid solution placed in the dark (no light irradiation) (sample 5), a folic acid solution without a polyphenol compound placed under an artificial meteor at 25 ° C. and 5,000 lux (sample 6) The folic acid solution (sample 7) to which only 100 μM (final concentration) of vitamin C (L-ascorbic acid; manufactured by Wako Pure Chemical Industries, Ltd.) was added was also tested.
After placing the sample for a certain period of time, folic acid was measured over time. As a control, the same concentration of vitamin C was used for comparison.
2.葉酸の測定;
葉酸の測定は、紫外部吸収検出器を備えた高速液体クロマトグラフィーを用いて行った。内径4.6mm、長さ150mmで粒子サイズ3μmのODSカラム(和光純薬株式会社製)を用い、12%アセトニトリル(0.05%リン酸を含む)を流速0.8mL/分で通液した。サンプルは0.45μmのフィルターに通した後、290nmでの紫外吸収をモニターリングすることにより葉酸の定量をした。
2. Measurement of folic acid;
The measurement of folic acid was performed using high performance liquid chromatography equipped with an ultraviolet absorption detector. Using an ODS column (made by Wako Pure Chemical Industries, Ltd.) having an inner diameter of 4.6 mm and a length of 150 mm and a particle size of 3 μm, 12% acetonitrile (including 0.05% phosphoric acid) was passed at a flow rate of 0.8 mL / min. . The sample was passed through a 0.45 μm filter, and folic acid was quantified by monitoring ultraviolet absorption at 290 nm.
3.カテキンの測定;
カテキンの測定は電気化学検出器を備えた高速液体クロマトグラフィーを用いて行った。内径4.6mm、長さ150mmで粒子サイズ3μmのODSカラム(和光純薬株式会社製)を用い、12%アセトニトリル(0.05%リン酸、0.01%エチレンジアミン四酢酸二ナトリウムを含む)を流速0.8mL/分で通液した。サンプルは0.45μmのフィルターを通した後、印加電圧500mVでの反応をモニターリングすることにより各カテキンの定量をした。
3. Catechin measurement;
Catechin was measured using high performance liquid chromatography equipped with an electrochemical detector. Using an ODS column (made by Wako Pure Chemical Industries, Ltd.) having an inner diameter of 4.6 mm and a length of 150 mm and a particle size of 3 μm, 12% acetonitrile (including 0.05% phosphoric acid and 0.01% ethylenediaminetetraacetate disodium) was used. The liquid was passed at a flow rate of 0.8 mL / min. The sample was passed through a 0.45 μm filter, and each catechin was quantified by monitoring the reaction at an applied voltage of 500 mV.
4.葉酸の経時安定性試験の結果;
上記経時安定性試験における結果(葉酸残存量)を図1に示す。
ポリフェノール類化合物なしの葉酸溶液(サンプル6)中の葉酸は、光照射条件下で1日目において全てが消失した。一方、ビタミンCのみ添加した葉酸溶液(サンプル7)では、ビタミンCの添加によって葉酸の劣化はやや抑制されたが、同濃度(10μM)で比較した場合に、ポリフェノール類化合物としてカテキン各種を添加したサンプル1〜4において、より長く葉酸が残存していた。これらのことにより、カテキン等のポリフェノール類の添加により、葉酸の安定性が増加したといえる。
また、葉に含まれるカテキンの種類による葉酸の安定化の違いを検討した結果、葉酸に対して0.1モル倍濃度(ECGの場合、重量比で0.01倍)でいずれのカテキン類も安定性改善の効果を有していた。また安定化の効果は、ECG>EC>EGCG>EGCの順に葉酸を安定化させる効果が高いことが分かった。
4). Results of folic acid stability over time;
The results (residual amount of folic acid) in the time stability test are shown in FIG.
All of the folic acid in the folic acid solution without the polyphenol compound (Sample 6) disappeared on the first day under light irradiation conditions. On the other hand, in the folic acid solution to which only vitamin C was added (sample 7), the deterioration of folic acid was somewhat suppressed by the addition of vitamin C, but various catechins were added as polyphenol compounds when compared at the same concentration (10 μM). In samples 1 to 4, folic acid remained longer. Therefore, it can be said that the stability of folic acid was increased by the addition of polyphenols such as catechin.
In addition, as a result of examining the difference in stabilization of folic acid depending on the type of catechin contained in the leaves, all catechins are 0.1 mol times the concentration of folic acid (in the case of ECG, 0.01 times by weight). It had the effect of improving stability. Moreover, it turned out that the effect of stabilization has a high effect which stabilizes folic acid in order of ECG>EC>EGCG> EGC.
1.ポリフェノールの濃度依存性試験
ポリフェノール類化合物としてエピカテキンガレート(ECG)の濃度を変化させた場合の濃度依存効果を検討した。結果を図2に示す。
20mLの50mMリン酸緩衝液(pH6)に葉酸(和光純薬工業株式会社製)100μM(終濃度。44.1mg/L)となるように溶解した。この葉酸溶液に、ポリフェノール類化合物として、エピカテキンガレート(ECG;分子量442)(フナコシ株式会社製)を5μM(サンプル8。2.21mg)、10μM(サンプル9。4.42mg)、20μM(サンプル10。8.84mg)(終濃度)添加して、これらサンプルを25℃、5,000ルクスの人工気象器(日本医化機械製作所製)下に置くことにより、葉酸の経時安定性を試験した。
同時に比較例として、葉酸溶液を暗黒下に置いたもの(光照射なし)(サンプル11)も同様に試験した。
サンプルを一定時間置いた後、経時的に葉酸の測定を行った。
その結果、最も濃度の低い5μM試験区(モル比で0.05倍、ECGの場合、重量比で0.05倍)でも葉酸の安定化効果が観察された。そして、その効果は添加量に依存しており、10μM(モル比で0.1倍、ECGの場合、重量比で約0.1倍。)および20μM、特に葉酸に対してモル比で0.2倍量の20μMではより高い葉酸安定化効果が見出された。
1. Concentration dependency test of polyphenol The concentration dependency effect when the concentration of epicatechin gallate (ECG) was changed as a polyphenol compound was examined. The results are shown in FIG.
In 20 mL of 50 mM phosphate buffer (pH 6), folic acid (manufactured by Wako Pure Chemical Industries, Ltd.) 100 μM (final concentration: 44.1 mg / L) was dissolved. In this folic acid solution, epicatechin gallate (ECG; molecular weight 442) (manufactured by Funakoshi Co., Ltd.) 5 μM (sample 8.2.21 mg), 10 μM (sample 9.4.42 mg), 20 μM (sample 10) was used as a polyphenol compound. 8.84 mg) (final concentration) was added, and the samples were placed under a 5,000-lux artificial meteor (manufactured by Nippon Kayaku Machinery Co., Ltd.) to test the folic acid stability over time.
At the same time, as a comparative example, a folic acid solution placed in the dark (no light irradiation) (sample 11) was also tested in the same manner.
After placing the sample for a certain period of time, folic acid was measured over time.
As a result, the stabilizing effect of folic acid was observed even in the 5 μM test group with the lowest concentration (molar ratio 0.05 times, in the case of ECG, 0.05 times weight ratio). The effect depends on the amount of addition, and is 10 μM (0.1 times in terms of molar ratio, about 0.1 times in terms of weight in the case of ECG) and 20 μM. A higher folic acid stabilization effect was found at twice the amount of 20 μM.
葉酸を含む飲料を調整し、ポリフェノールによる安定化の試験を行った。各サンプルの製造方法は以下の通りである。 A beverage containing folic acid was prepared and tested for stabilization with polyphenols. The manufacturing method of each sample is as follows.
実施例A
緑茶抽出物(テアフラン90S、株式会社伊藤園製)を1g/Lとなるようにイオン交換水に溶解し、葉酸(関東化学株式会社製)を終濃度で22mg/Lとなるように添加した。この溶液10mLをネジ付き試験管に入れ、121℃、20分間オートクレーブ処理した。
Example A
Green tea extract (Teafuran 90S, manufactured by ITO EN Co., Ltd.) was dissolved in ion-exchanged water so as to be 1 g / L, and folic acid (manufactured by Kanto Chemical Co., Ltd.) was added to a final concentration of 22 mg / L. 10 mL of this solution was placed in a threaded test tube and autoclaved at 121 ° C. for 20 minutes.
実施例B
ウーロン茶葉100gに熱湯1Lを加え、10分間放置後、茶葉を取り除いた。その後、5000×gで20分、室温で遠心分離を行い、濃縮・乾固した。このウーロン茶エキス末を4g/Lとなるようにイオン交換水に溶解し、葉酸とビタミンCをそれぞれ終濃度で4.4mg/L、0.3g/Lをとなるように添加した。この溶液10mLをネジ付き試験管に入れ、121℃、20分間オートクレーブ処理した。
Example B
1 L of hot water was added to 100 g of oolong tea leaves, and the tea leaves were removed after standing for 10 minutes. Thereafter, the mixture was centrifuged at 5000 × g for 20 minutes at room temperature, and concentrated and dried. This oolong tea extract powder was dissolved in ion-exchanged water so as to be 4 g / L, and folic acid and vitamin C were added to final concentrations of 4.4 mg / L and 0.3 g / L, respectively. 10 mL of this solution was placed in a threaded test tube and autoclaved at 121 ° C. for 20 minutes.
実施例C
ダッタンソバ実を100gに対し、1.25Lの95℃の熱水を加え、20分間抽出した。抽出液を冷却後、そば実とメッシュろ過し、3000回転で15分間遠心分離した。このソバ抽出液を濃縮し、凍結乾燥した。このソバエキス末を1g/Lとなるようにイオン交換水に懸濁させ、4.4mg/Lとなるように葉酸を添加した。この溶液10mLをネジ付き試験管に入れ、121℃、20分間オートクレーブ処理した。
Example C
1.25 L of 95 ° C. hot water was added to 100 g of tartary buckwheat and extracted for 20 minutes. The extract was cooled, then filtered with buckwheat and meshed, and centrifuged at 3000 rpm for 15 minutes. The buckwheat extract was concentrated and lyophilized. This buckwheat extract powder was suspended in ion-exchanged water so as to be 1 g / L, and folic acid was added so as to be 4.4 mg / L. 10 mL of this solution was placed in a threaded test tube and autoclaved at 121 ° C. for 20 minutes.
実施例D
麦茶10gに対し、イオン交換水を1L加え、10分間煮沸した。この麦茶抽出液に対し、葉酸を33mg/Lとなるように添加し、この溶液10mLをネジ付き試験管に入れ、121℃、20分間オートクレーブ処理した。
Example D
1 L of ion exchange water was added to 10 g of barley tea and boiled for 10 minutes. To this barley tea extract, folic acid was added to a concentration of 33 mg / L, and 10 mL of this solution was placed in a test tube with a screw and autoclaved at 121 ° C. for 20 minutes.
比較例
イオン交換水に葉酸を44mg/Lとなるように添加し、121℃、20分間オートクレーブ処理した。調製したサンプルを25℃、5,000ルクスの人工気象器に8日間置くことにより、葉酸の経時安定性を試験した。
Comparative Example Folic acid was added to ion-exchanged water to a concentration of 44 mg / L, and autoclaved at 121 ° C. for 20 minutes. The stability of folic acid over time was tested by placing the prepared sample in an climatic instrument at 25 ° C. and 5,000 lux for 8 days.
ポリフェノール類の測定
ポリフェノール類の測定はフォーリンデニス法、高速液体クロマトグラフィー法を用いて行った。フォーリンデニス法は、タンニン酸(ナカライテスク株式会社)を標準物質とした。
Measurement of polyphenols Polyphenols were measured using the foreign dennis method and the high performance liquid chromatography method. The foreign dennis method used tannic acid (Nacalai Tesque Co., Ltd.) as a standard substance.
結果を表1に示す。 The results are shown in Table 1.
(結果)
比較例は、葉酸残存率が0になった一方で、実施例A、B、C、Dの葉酸含有飲料は、それぞれ約70%、70%、85%、55%であり、特に実施例A、B、Cでは約70%、85%の残存率という高い葉酸残存率を維持した。
(result)
In the comparative example, the residual ratio of folic acid was 0, while the folic acid-containing beverages of Examples A, B, C, and D were about 70%, 70%, 85%, and 55%, respectively. , B, and C maintained high folic acid residual ratios of about 70% and 85%.
本発明によれば、ポリフェノール類、特にカテキン類を共存させることにより葉酸を安定的に保持することができる。したがって、店頭等において照射条件下に曝されるPETボトル詰め葉酸含有飲料において効果的に適用できる。 According to the present invention, folic acid can be stably retained by the coexistence of polyphenols, particularly catechins. Therefore, the present invention can be effectively applied to PET bottle-packed folic acid-containing beverages that are exposed to irradiation conditions in stores or the like.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005127014A JP4545632B2 (en) | 2005-04-25 | 2005-04-25 | Folic acid-containing composition and method for stabilizing folic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005127014A JP4545632B2 (en) | 2005-04-25 | 2005-04-25 | Folic acid-containing composition and method for stabilizing folic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006296379A JP2006296379A (en) | 2006-11-02 |
JP4545632B2 true JP4545632B2 (en) | 2010-09-15 |
Family
ID=37465242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005127014A Active JP4545632B2 (en) | 2005-04-25 | 2005-04-25 | Folic acid-containing composition and method for stabilizing folic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4545632B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101868156B (en) | 2007-11-16 | 2014-03-12 | 协和发酵生化株式会社 | Citrulline-containing drink |
DE102007062323A1 (en) * | 2007-12-21 | 2009-06-25 | Siemens Healthcare Diagnostics Products Gmbh | Long-term stable thromboplastin reagent |
JP5849384B2 (en) * | 2009-08-12 | 2016-01-27 | 大正製薬株式会社 | Folic acid-containing beverage |
JP6710900B2 (en) * | 2015-04-30 | 2020-06-17 | ユーハ味覚糖株式会社 | Method for producing water-soluble vitamin-containing gummy candy and gummy candy obtained by using the method |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001011441A (en) * | 1999-05-28 | 2001-01-16 | Johnson & Johnson Consumer Co Inc | Composition and process for stabilizing oxygen-unstable species |
JP2001506579A (en) * | 1996-09-20 | 2001-05-22 | ザ・ハワード・ファウンデイション | Supplement containing flavonols |
JP2001238640A (en) * | 2000-02-28 | 2001-09-04 | Snow Brand Milk Prod Co Ltd | Folic acid and/or vitamin b12-lactoferrin complex |
JP2002142677A (en) * | 2000-11-17 | 2002-05-21 | Kao Corp | Packaged beverage |
JP2002272373A (en) * | 2002-03-18 | 2002-09-24 | Kao Corp | Method for producing bottled drink |
JP2003503324A (en) * | 1999-06-29 | 2003-01-28 | イクセル・ハーバシューティカルズ | Effervescent green tea extract preparation |
JP2004248659A (en) * | 2003-02-20 | 2004-09-09 | Kogetsuen Chaho:Kk | Nutrient-enriched green tea powder |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0631237B2 (en) * | 1985-06-11 | 1994-04-27 | 三井東圧化学株式会社 | Method for preserving and stabilizing 5,6,7,8-tetrahydrofolic acid and its derivatives |
ES2076263T3 (en) * | 1989-08-21 | 1995-11-01 | American Cyanamid Co | STABLE INJECTABLE PHARMACEUTICAL FORMULATION, FOR FOLIC ACID AND LEUKOVORINE SALTS AND PROCEDURE. |
-
2005
- 2005-04-25 JP JP2005127014A patent/JP4545632B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001506579A (en) * | 1996-09-20 | 2001-05-22 | ザ・ハワード・ファウンデイション | Supplement containing flavonols |
JP2001011441A (en) * | 1999-05-28 | 2001-01-16 | Johnson & Johnson Consumer Co Inc | Composition and process for stabilizing oxygen-unstable species |
JP2003503324A (en) * | 1999-06-29 | 2003-01-28 | イクセル・ハーバシューティカルズ | Effervescent green tea extract preparation |
JP2001238640A (en) * | 2000-02-28 | 2001-09-04 | Snow Brand Milk Prod Co Ltd | Folic acid and/or vitamin b12-lactoferrin complex |
JP2002142677A (en) * | 2000-11-17 | 2002-05-21 | Kao Corp | Packaged beverage |
JP2002272373A (en) * | 2002-03-18 | 2002-09-24 | Kao Corp | Method for producing bottled drink |
JP2004248659A (en) * | 2003-02-20 | 2004-09-09 | Kogetsuen Chaho:Kk | Nutrient-enriched green tea powder |
Also Published As
Publication number | Publication date |
---|---|
JP2006296379A (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7458657B2 (en) | packaged beverages | |
CN1248602C (en) | Packaged drink | |
JP3590051B1 (en) | Packaged beverage | |
US8088429B2 (en) | Package drink | |
TWI451844B (en) | Production process of purified green tea extract | |
TWI411403B (en) | Production process of purified green tea extract | |
TWI402041B (en) | Concentrated compositions for reduced beverages | |
JP4690877B2 (en) | Containerized tea beverage | |
JP2006315985A (en) | Method for suppressing deterioration of vitamin | |
EP1695630B1 (en) | Bottled beverage | |
JP5517421B2 (en) | Container drink | |
JP2009247215A (en) | Bottled drink | |
EP2036551B1 (en) | Catechins for improving muscle power | |
JP4545632B2 (en) | Folic acid-containing composition and method for stabilizing folic acid | |
JP2009034076A (en) | Packaged beverage | |
EA018213B1 (en) | Precursor of food product, food additive or beverage | |
JP2017099293A (en) | Packed beverage | |
JP3615213B1 (en) | Container drink | |
JP4774002B2 (en) | Container drink | |
JP5523303B2 (en) | Stabilizing composition containing high-intensity sweetener | |
TW202205968A (en) | Container-packed aspalathin-containing beverage, method for producing same, and method for improving storage stability of aspalathin in container-packed aspalathin-containing beverage | |
JP2008031148A (en) | Agent for improving muscle power | |
JP2005245351A (en) | Acidic beverage | |
JP4571559B2 (en) | Container drink | |
JP4074579B2 (en) | Container drink |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061109 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20061020 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090918 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091116 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20091124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100223 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100419 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100601 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100630 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130709 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4545632 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160709 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |